DIBENZOXEPIN DERIVATIVES - THROMBOXANE-A(2) SYNTHASE INHIBITION AND THROMBOXANE A(2)-RECEPTOR ANTAGONISM COMBINED IN ONE MOLECULE

被引:11
|
作者
OHSHIMA, E
SATO, H
OBASE, H
MIKI, I
ISHII, A
KAWAKAGE, M
SHIRAKURA, S
KARASAWA, A
KUBO, K
机构
[1] Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, 411, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun
关键词
D O I
10.1021/jm00063a011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of 6,11-dihydrodibenz[b,e]oxepin derivatives exerting both thromboxane synthase inhibitory (TXS-I) and thromboxane receptor antagonist (TXRA) activities is described. (-)-ll-[(3-Pyridylmethyl)thio]-6,11-dihydrodibenz[b,e]oxepin-2-carboxylic acid [(-)-3] and (E)-11-[2-(3-pyridyl)ethylidene]-6,11-dihydrodibenz[b,e]oxepin-2-carboxylic acid methanesulfonate (11E) exhibited potent inhibitory effects on bovine platelet thromboxane synthase with IC50 values of 4.0 and 14 nM, respectively, and these derivatives also antagonized guinea pig platelet TXA2/PGH2 receptors with K(i) values of 85 and 180 nM, respectively. Compound 11E exhibited the dual inhibitory activity in ex vivo experiments and demonstrated a significant protective effect in a rat acute renal failure model.
引用
收藏
页码:1613 / 1618
页数:6
相关论文
共 50 条
  • [11] THROMBOXANE RECEPTOR ANTAGONISM AND SYNTHASE INHIBITION IN CEREBRAL-ISCHEMIA
    PETTIGREW, LC
    KRYSCIO, RJ
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1993, 48 (03): : 211 - 217
  • [12] Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors
    Soyka, R
    Guth, BD
    Weisenberger, HM
    Luger, P
    Müller, T
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (07) : 1235 - 1249
  • [13] THROMBOXANE RECEPTOR ANTAGONISM COMBINED WITH THROMBOXANE SYNTHASE INHIBITION .6. 4-SUBSTITUTED 3-PYRIDINYLALKANOIC ACIDS
    BHAGWAT, SS
    BOSWELL, C
    GUDE, C
    CONTARDO, N
    COHEN, DS
    MATHIS, J
    DOTSON, R
    LEE, W
    SHETTY, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (12) : 1619 - 1622
  • [14] THROMBOXANE SYNTHASE INHIBITION COMBINED WITH THROMBOXANE RECEPTOR BLOCKADE - A STEP FORWARD IN ANTITHROMBOTIC STRATEGY
    GRESELE, P
    VANHOUTTE, E
    ARNOUT, J
    DECKMYN, H
    VERMYLEN, J
    THROMBOSIS AND HAEMOSTASIS, 1984, 52 (03) : 364 - 364
  • [15] THE IN-VIVO ANTIPLATELET EFFECTS OF THROMBOXANE-A(2) SYNTHASE INHIBITORS ARE POTENTIATED BY SIMULTANEOUS THROMBOXANE A(2)/PROSTAGLANDIN-H-2 RECEPTOR BLOCKADE
    GOLINO, P
    AMBROSIO, G
    GRESELE, P
    PASCUCCI, I
    RAGNI, M
    RUSSOLILLO, E
    LEPROUX, GB
    CHIARIELLO, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 266 (02): : 511 - 517
  • [16] Thromboxane A2 receptor antagonism and selective inhibition of cyclooxygenase 2 in atherosclerosis
    Egan, KM
    Wang, M
    Lucitt, M
    Lawson, J
    FitzGerald, GA
    CIRCULATION, 2004, 110 (17) : 177 - 177
  • [17] THROMBOXANE RECEPTOR ANTAGONISM COMBINED WITH THROMBOXANE SYNTHASE INHIBITION .8. N-ALKYLATION OF INDOLE RING USING MITSUNOBU REACTION
    BHAGWAT, SS
    GUDE, C
    TETRAHEDRON LETTERS, 1994, 35 (12) : 1847 - 1850
  • [18] THROMBOXANE DOES NOT PLAY A SIGNIFICANT ROLE IN ACUTE, COLD-INDUCED VASOCONSTRICTION IN RAYNAUDS-PHENOMENON - STUDIES WITH COMBINED THROMBOXANE SYNTHASE INHIBITION AND THROMBOXANE RECEPTOR ANTAGONISM
    GRESELE, P
    VOLPATO, R
    MIGLIACCI, R
    VEZZA, R
    BOSCHETTI, E
    NENCI, GG
    THROMBOSIS RESEARCH, 1992, 66 (2-3) : 259 - 264
  • [19] SYNTHESIS AND EVALUATION OF NOVEL SULFONAMIDE DERIVATIVES AS THROMBOXANE-A(2) RECEPTOR ANTAGONISTS-I
    SATO, M
    KAWASHIMA, Y
    GOTO, J
    YAMANE, Y
    CHIBA, Y
    JINNO, S
    SATAKE, M
    IWATA, C
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1994, 29 (03) : 185 - 190
  • [20] MODELING OF HUMAN THROMBOXANE-A(2) RECEPTOR AND ANALYSIS OF THE RECEPTOR LIGAND INTERACTION
    YAMAMOTO, Y
    KAMIYA, K
    TERAO, S
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (07) : 820 - 825